First Reach™

Everyday First-Response Body Oil · Arnica · Calendula · Roman Chamomile

Core Formula · Available Year-Round

Overview

First Reach™ is made for minor, everyday physical discomfort on intact skin.

Its place is different from Athlete Magic™. Athlete Magic™ is a post-exertion formula for worked muscles, joints, and connective tissue. First Reach™ belongs earlier and on a smaller scale: the ordinary bump, knock, or localized area that feels tender after impact.

The formula is built principally from CO₂ extracts because the materials selected contribute constituent fractions that are not represented in the same way by a conventional essential-oil blend.

Arnica provides its characteristic sesquiterpene-lactone fraction. Calendula contributes lipophilic triterpenoids, including faradiol esters. Ginger contributes gingerols, shogaols, and related pungent constituents. Turmeric contributes a lipophilic rhizome fraction characterized by turmerones and other extraction-dependent constituents.

Roman Chamomile contributes a chemically distinct essential oil, characterized by angelate esters and a smaller sesquiterpene-lactone fraction.

Questions & Answers

The Formula

First Reach™ combines CO₂ extracts of Arnica, Calendula, Turmeric, and Ginger with Roman Chamomile essential oil. Each material was selected for a specific, chemically distinct constituent fraction.

Arnica CO₂ is the centre of the formula. Supercritical extraction concentrates Arnica's sesquiterpene-lactone fraction, including helenalin- and dihydrohelenalin-derived constituents. Helenalin has been shown to inhibit NF-κB signalling in experimental models, and a randomized controlled trial found that a 20% topical Arnica preparation improved resolution of laser-induced bruising compared with some comparators. That preparation and concentration differ from First Reach™; the study establishes topical relevance for Arnica generally, not an effect of this formula.

Calendula CO₂ contributes lipophilic triterpenoids, particularly faradiol monoesters, identified in fractionation studies as the constituent group most closely tracking Calendula's topical anti-inflammatory activity. In a randomized double-blind trial, an emollient containing 1% supercritical Calendula CO₂ improved hydration and accelerated recovery of transepidermal water loss after experimentally induced irritant contact dermatitis. It did not significantly improve erythema.

Turmeric CO₂ contributes ar-turmerone, α-turmerone, and β-turmerone. Curcuminoid content depends heavily on extraction conditions, so the material is included for its broader lipophilic rhizome fraction rather than as a concentrated curcumin source.

Ginger CO₂ contributes gingerols and shogaols — a pungent, less-volatile fraction not present in the same way in steam-distilled Ginger essential oil. It is used at a proportion intended to provide restrained warmth rather than the heat of a sports liniment.

Roman Chamomile essential oil contributes two constituent classes not present in the CO₂ extracts: angelate esters (isobutyl angelate, isoamyl angelate, and related compounds), which dominate the distilled oil, and germacranolide-type sesquiterpene lactones, including nobilin, present in smaller amounts. In one rodent study, C. nobile essential oil produced anti-inflammatory and analgesic effects comparable to ibuprofen; that sample was dominated by α-bisabolol rather than esters, illustrating that chemotype varies within the species. A separate Bulgarian comparative study found C. nobile oil's anti-inflammatory activity, measured by inhibition of albumin denaturation, comparable to prednisolone and stronger than German Chamomile oil tested under the same method. In isolated organ-bath experiments, Roman Chamomile essential oil also produced smooth-muscle relaxation in rat intestinal tissue and human jejunum preparations, with no contractile activity observed. Each of these studies tested the whole essential oil rather than isolating which constituent class is responsible for the effect.

Formulation Logic

RESEARCH-FORMULATED™ · Formulation Logic, Applied.

We look at botanical identity, extraction method, constituent chemistry, published research, and the role each material needs to play inside the finished formula.

First Reach™ brings Arnica, Calendula, Turmeric, and Ginger CO₂ extracts together with Roman Chamomile essential oil, using each for a different part of the formulation rather than asking one botanical to do everything.

What do we do with that knowledge? We formulate.

Aromatic Profile

Mild and low-intensity.

Ginger and Turmeric contribute a faint spice note. Roman Chamomile is the most aromatically noticeable material in the blend. Calendula and Arnica CO₂ contribute comparatively little scent.

The aroma is faint at the skin's surface and is not intended to be perceptible as a fragrance.

How We Use It

Apply a small amount to intact skin after an ordinary bump, knock, or other minor localized physical discomfort.

Use enough to cover the area lightly. First Reach™ does not require vigorous massage; spread it gently over the skin and allow the formula to remain in place.

Suitable areas may include the hands, arms, knees, shins, elbows, or other small localized areas.

Reapply as needed. First Reach™ was formulated for small-area use rather than full-body massage.

Ingredients

CO₂ extracts of: Arnica, Turmeric, Ginger, and Calendula (Marigold)

Essential oil of: Roman Chamomile

In a base of: lightweight, virtually odorless MCT oil, selected for easy spread and a clean emollient finish without the weight of a richer fixed oil.

Character & Feel

• Lightweight and easy to spread over a localized area
• Mildly warm rather than hot
• No menthol or pronounced cooling effect
• Low-intensity aroma, not perceptible as fragrance
• Intended for small, ordinary physical knocks and localized tenderness rather than post-workout recovery or full-body massage

Notes and Cautions

• For external use only. Apply only to intact skin.
• Do not apply to open wounds, cuts, scrapes, broken or blistered skin, active burns, surgical incisions, or mucous membranes. Avoid contact with the eyes.
• Arnica, Calendula, and Roman Chamomile belong to the Asteraceae family. Do not use if you have a known sensitivity to Arnica, chamomile, marigold, ragweed, daisies, or related plants.
• Patch test before first use, particularly on sensitive or reactive skin. Discontinue use if redness, itching, burning, blistering, or other irritation develops.
• Avoid prolonged continuous application to the same area.
• The safety of the finished formula during pregnancy, breastfeeding, and use in children has not been established. Seek qualified guidance before use in these groups.
• First Reach™ is intended only for minor, everyday physical discomfort. Severe or worsening pain, substantial swelling, restricted movement, suspected fracture, signs of infection, significant burns, unexplained bruising, or symptoms that do not begin to improve require appropriate medical assessment.
• Store tightly closed, away from heat and direct light.

See Safety & Responsible Use for Ananda's general guidance.

Lineage Note

First Reach™ reflects an Ananda formulation principle: not every physical need requires an intensive formula.

Some Ananda preparations are built for post-exertion recovery, sustained massage, or pronounced warming action. First Reach™ was formulated for smaller, more localized use, at an earlier stage of physical discomfort than those formulas address.

Legacy Archive: traditional-use context, constituent notes, and formulation logic for First Reach™ →

Availability and Sizes

First Reach™ is a Core Formula · Available Year-Round.

Botanical extracts vary naturally between harvests and production lots. Minor differences in aroma, colour, and viscosity may occur as materials change while the formulation itself remains consistent.

Available size: 30 mL

Further Study

For those interested, a selection of research relating to some of the materials in this formula. These studies examine individual botanicals or extracts in laboratory or small human studies; they do not evaluate First Reach™ itself or establish that it treats injury, inflammation, bruising, pain, or any medical condition.

Bilia AR, Bergonzi MC, Mazzi G, Vincieri FF. NMR Spectroscopy: A Useful Tool for Characterisation of Plant Extracts, the Case of Supercritical CO₂ Arnica Extract. Journal of Pharmaceutical and Biomedical Analysis. 2002;30(2):321–330. doi:10.1016/S0731-7085(02)00279-0.
Analysis of a supercritical Arnica montana extract characterized the sesquiterpene-lactone fraction, including helenalin- and dihydrohelenalin-derived constituents. This study is directly relevant to the decision to use Arnica as a CO₂ extract rather than treating Arnica merely as a traditional botanical name.
https://pubmed.ncbi.nlm.nih.gov/12191718/

Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I. The Anti-Inflammatory Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly Targeting p65. Biological Chemistry. 1997;378(9):951–961. doi:10.1515/bchm.1997.378.9.951.
Helenalin inhibited NF-κB signalling in experimental models. The study helps explain why Arnica's sesquiterpene-lactone fraction is biologically relevant, but it is mechanistic evidence rather than evidence that First Reach™ suppresses inflammation.
https://pubmed.ncbi.nlm.nih.gov/9348104/

Leu S, Havey J, White LE, et al. Accelerated Resolution of Laser-Induced Bruising with Topical 20% Arnica: A Rater-Blinded Randomized Controlled Trial. British Journal of Dermatology. 2010;163(3):557–563. doi:10.1111/j.1365-2133.2010.09813.x.
In a standardized laser-induced bruising model, a concentrated 20% topical Arnica preparation produced greater improvement than some comparator treatments. The preparation and concentration differ from First Reach™, so the study establishes human topical relevance for Arnica rather than demonstrating an effect of this formula.
https://pubmed.ncbi.nlm.nih.gov/20412090/

Della Loggia R, Tubaro A, Sosa S, Becker H, Saar S, Isaac O. The Role of Triterpenoids in the Topical Anti-Inflammatory Activity of Calendula officinalis Flowers. Planta Medica. 1994;60(6):516–520. doi:10.1055/s-2006-959562.
Fractionation of Calendula CO₂ extracts identified triterpenoids as an important active fraction. Activity among the extracts correlated particularly with faradiol monoester content. This gives the use of Calendula CO₂ in First Reach™ a specific constituent-level rationale.
https://pubmed.ncbi.nlm.nih.gov/7809203/

Šušak Crnčević M, Durdov T, Rušić D, et al. Double-Blind Randomised Controlled Trial of an Emollient Cream With and Without 1% Supercritical CO₂ Extract of Calendula officinalis in Contact Dermatitis. Acta Pharmaceutica. 2025;75(4):699–708. doi:10.2478/acph-2025-0035.
Twenty healthy volunteers participated in a randomized, double-blind study comparing an emollient containing 1% supercritical Calendula CO₂ with the base emollient after experimentally induced irritant contact dermatitis. The Calendula CO₂ preparation improved hydration and accelerated recovery of transepidermal water loss. It did not significantly improve erythema. The study is particularly relevant to the formulation because it examines a human topical preparation containing the same extraction type used in First Reach™.
https://doi.org/10.2478/acph-2025-0035

Sonale RS, Kadimi US. Characterization of Gingerol Analogues in Supercritical Carbon Dioxide Extract of Ginger (Zingiber officinale). Journal of Food Science and Technology. 2014;51(11):3383–3389. doi:10.1007/s13197-012-0851-4.
Chemical characterization of a supercritical Ginger CO₂ extract identified several gingerols and shogaols, including substantial 6-gingerol. The study directly supports the choice of Ginger CO₂ when the formulation objective includes the pungent rhizome fraction rather than only the volatile constituents present in distilled Ginger essential oil.
https://pubmed.ncbi.nlm.nih.gov/26396335/

Rodriguez Justo O, Moraes AM, Barreto GP, Mercadante AZ. Biological Activities of Ginger Extracts Produced by Supercritical CO₂ Extraction. 2015. doi:10.1186/s12906-015-0896-9.
Experimental work with supercritical Ginger CO₂ extracts examined inflammatory signalling and found reductions in nitric oxide and inflammatory cytokine production in stimulated macrophage models. This is preclinical evidence. Its relevance here is that biological activity was examined in the supercritical extract itself rather than inferred solely from isolated ginger constituents.
https://pubmed.ncbi.nlm.nih.gov/26511466/

Widmann AK, Wahl MA, Kammerer DR. Supercritical Fluid Extraction with CO₂ of Curcuma longa L. in Comparison to Conventional Solvent Extraction. Pharmaceutics. 2022;14(9):1943. doi:10.3390/pharmaceutics14091943.
This study characterized supercritical Turmeric extracts for curcumin, demethoxycurcumin, bisdemethoxycurcumin, ar-turmerone, α-turmerone, and β-turmerone. The results also demonstrated that extraction conditions materially affect the constituent profile obtained. It therefore supports both the choice of a lipophilic Turmeric CO₂ fraction and Ananda's decision not to describe an unspecified Turmeric CO₂ extract generically as "curcumin-rich."
https://pubmed.ncbi.nlm.nih.gov/36145691/

Such S, Zaguła G, Puchalski C, Czernicka M. German and Roman Chamomile: Species-Specific Phytochemical Profiles, Bioactive Potential, and Relevance for Functional Foods and Nutraceutical Development. Nutrients. 2026;18(13):2181. doi:10.3390/nu18132181.
A comparative review confirming that Roman Chamomile essential oil is characterized by angelate esters (isobutyl angelate, isoamyl angelate) and germacranolide-type sesquiterpene lactones (including nobilin), a chemically distinct profile from German Chamomile's bisabolol- and chamazulene-dominated oil. The review states explicitly that the two species should not be treated as interchangeable — the basis for distinguishing Roman Chamomile's role in First Reach™ from German Chamomile research elsewhere on this site.
https://doi.org/10.3390/nu18132181

Aremu OO, Tata CM, Sewani-Rusike CR, Oyedeji AO, Oyedeji OO, Nkeh-Chungag BN. Phytochemical Composition, and Analgesic and Antiinflammatory Properties of Essential Oil of Chamaemelum nobile (Asteraceae L All) in Rodents. Tropical Journal of Pharmaceutical Research. 2018;17(10):1939–1945. doi:10.4314/tjpr.v17i10.7.
Oral administration of C. nobile essential oil (180 mg/kg) significantly reduced pain in mouse chemical and thermal pain models and prevented inflammation in a rat egg albumin-induced inflammation model, at effects comparable to ibuprofen (100 mg/kg). The tested oil was dominated by α-bisabolol (50%) rather than esters — a reminder that Roman Chamomile's chemical profile varies by chemotype and growing conditions, not only by species.
https://doi.org/10.4314/tjpr.v17i10.7

Batovska D, Panova N, Gerasimova A, Tumbarski Y, Ivanov I, Dincheva I, Yotkovska I, Gentscheva G, Nikolova K. Chamomile Matters: Species- and Producer-Dependent Variation in Bulgarian Matricaria recutita L. and Chamaemelum nobile L. Essential Oils and Their Cosmetic Potential. Cosmetics. 2025;12(3):123. doi:10.3390/cosmetics12030123.
GC-MS analysis confirmed Roman Chamomile oils were dominated by isobutyl angelate and related esters, distinct from German Chamomile's β-farnesene, chamazulene, and bisabolol-oxide profile. In an albumin-denaturation assay, Roman Chamomile oil's anti-inflammatory activity was comparable to prednisolone and stronger than German Chamomile oil tested by the same method.
https://doi.org/10.3390/cosmetics12030123

Sándor Z, Mottaghipisheh J, Veres K, Hohmann J, Bencsik T, Horváth A, Kelemen D, Papp R, Barthó L, Csupor D. Evidence Supports Tradition: The in Vitro Effects of Roman Chamomile on Smooth Muscles. Frontiers in Pharmacology. 2018;9:323. doi:10.3389/fphar.2018.00323.
In isolated organ-bath experiments using guinea pig, rat, and human tissue, Roman Chamomile essential oil produced smooth-muscle relaxation — 41.4% in rat ileum and 21.8% in rat distal colon, relative to isoprenaline — with no contractile activity observed. The essential oil was also tested against human jejunum preparations. This is in-vitro tissue research; it does not test topical skin application or First Reach™ itself.
https://doi.org/10.3389/fphar.2018.00323

The information provided on this page has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. For external topical use only.